Gero is a longevity biotech company founded by a team of scientists and entrepreneurs with extensive experience in the area of life sciences. Our goal is to extend healthy lifespan dramatically and delay age-related health issues.
We identify novel anti-aging targets, develop life-extending therapies and estimate personal risks of diseases and mortality with the help of AI and proprietary models.
N/A
26 to 50
Series A
$2,200,000
N/A
2015
Pharmaceuticals and Medical Products
Healthcare
N/A
N/A
N/A
Yes
Active
Machine Learning
Natural Language Processing
N/A
Software